THBS2 and neoplasm: Mir-20a targets the thrombospondin 2 (THBS2) gene, which codes for a matricellular glycoprotein involved in the regulation of multiple biological processes, which has been characterized alternately as a tumor suppressor or as an oncogenic factor.